Please assess the completion status of the following clinical trial:

Trial Title: Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with non-investigated/functional dyspepsia or scarred peptic ulcer with indication of H pylori eradication treatment~* Ability and willingness to participate in the study and to sign and give informed consent~* confirmed H pylori infection by at least one of the following methods: C13-urea breath test, histology, rapid urease test or bacterial culture.~Exclusion Criteria:~* patients with peptic ulcer~* previous H. pylori eradication therapy~* Age below 18 years~* major systemic diseases~* previous gastric surgery~* pregnancy or breastfeeding~* allergy to any of the study drugs~* receipt of anti-secretory therapy, antibiotics or bismuth salts 4 weeks prior to inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Amoxicillin/metronidazole (Type: EXPERIMENTAL): Amoxicillin/metronidazole-based quadruple therapy for 14 days: Lansoprazole 30mg bid, Bismuth Potassium Citrate 220mg bid, amoxicillin 1000mg bid, Metronidazole 400mg qid
- Amoxicillin/clarithromycin (Type: ACTIVE_COMPARATOR): Amoxicillin/clarithromycin-based quadruple therapy for 14 days: Lansoprazole 30mg bid, Bismuth Potassium Citrate 220mg bid, Amoxicillin 1000mg bid, Clarithromycin 500mg bid

Based on this trial design, predict the completion outcome and termination type (if applicable).